{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:00:33Z","timestamp":1787169633258,"version":"build-2736575974"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Drug-induced priapism is well known and papaverine is the most common drug known to cause priapism. Drotaverine, an analog of papaverine, is used extensively to treat Colicky pain. We report the first case of drotaverine.induced priapism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/iju.iju_240_20","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T06:12:09Z","timestamp":1691820729000},"page":"90-91","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Drotaverine-induced priapism"],"prefix":"10.4103","volume":"37","author":[{"given":"Ajay Shyam","family":"Kanbur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muktachand L","family":"Rokade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20240903","first-page":"46","article-title":"Drug-induced priapism. Its aetiology, incidence and treatment","volume":"4","author":"Ba\u00f1os","year":"1989","journal-title":"Med Toxicol Adverse Drug Exp"},{"key":"R2-18-20240903","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1743-6109.2009.01625.x","article-title":"Priapism: Pathogenesis, epidemiology, and management","volume":"7","author":"Broderick","year":"2010","journal-title":"J Sex Med"},{"key":"R3-18-20240903","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fphar.2012.00167","article-title":"PDE5 inhibitors as potential tools in the treatment of cystic fibrosis","volume":"3","author":"Noel","year":"2012","journal-title":"Front Pharmacol"},{"key":"R4-18-20240903","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF03189716","article-title":"Pharmacokinetics and bioavailability of drotaverine in humans","volume":"21","author":"Bolaji","year":"1996","journal-title":"Eur J Drug Metab Pharmacokinet"}],"container-title":["Indian Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/iju.IJU_240_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:11:27Z","timestamp":1787166687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/iju.IJU_240_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":4,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/iju.iju_240_20","relation":{},"ISSN":["0970-1591"],"issn-type":[{"value":"0970-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}